Valuation: Ningbo Menovo Pharmaceutical Co., Ltd.

Market Cap 9.72B 1.45B 1.29B 1.2B 1.1B 2.07B 139B 2.09B 14.55B 5.64B 71.23B 5.44B 5.32B 229B P/E 2024
41x
P/E 2025 40.9x
Enterprise Value 10.3B 1.54B 1.37B 1.27B 1.16B 2.19B 148B 2.21B 15.42B 5.98B 75.52B 5.77B 5.64B 242B EV / Sales 2024
2.46x
EV / Sales 2025 3.21x
Free-Float
70.49%
Yield 2024
0.39%
Yield 2025 0.81%
1 day+10.00%
1 week+6.84%
1 month+4.65%
3 months+3.13%
6 months+0.07%
Current year+108.04%
1 week 25.68
Extreme 25.68
28.59
1 month 24.9
Extreme 24.9
29.39
Current year 13.71
Extreme 13.714285
50.28
1 year 13.55
Extreme 13.549999
50.28
3 years 7.11
Extreme 7.114285
50.28
5 years 7.11
Extreme 7.114285
50.28
10 years 6.9
Extreme 6.902446
50.28
Manager TitleAgeSince
Chief Executive Officer 52 2004-02-18
Director of Finance/CFO 55 2021-05-11
Investor Relations Contact 39 -
Director TitleAgeSince
Chairman 52 2004-02-18
Chairman 37 2021-05-11
Director/Board Member 55 2021-05-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/22 Sell

Director

44,300 0.0210%
11/14/22 Sell 13,500 0.0064%
7/12/22 Buy

Chief Executive Officer

3,430,253 1.6290%
Change 5-day change 1-year change 3-year change Capi.($)
+10.00%+6.84%+84.03%+116.01% 1.45B
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
-0.95%-4.05%+20.54%+41.71% 333B
-1.46%-2.89%+10.57%+32.81% 267B
-1.35%-5.43%-6.17%+8.98% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average +0.32%-2.76%+31.87%+64.39% 369.86B
Weighted average by Cap. -0.59%-3.32%+29.09%+70.58%

Financials

2024 2025
Net sales 1.37B 205M 182M 170M 155M 292M 19.68B 295M 2.05B 796M 10.06B 769M 752M 32.29B 1.5B 224M 199M 186M 169M 320M 21.55B 323M 2.25B 872M 11.02B 842M 823M 35.36B
Net income 66.81M 9.96M 8.85M 8.26M 7.53M 14.2M 958M 14.34M 99.99M 38.75M 490M 37.41M 36.6M 1.57B 102M 15.25M 13.55M 12.64M 11.52M 21.74M 1.47B 21.94M 153M 59.29M 749M 57.25M 56M 2.4B
Net Debt 602M 89.74M 79.73M 74.41M 67.83M 128M 8.63B 129M 901M 349M 4.41B 337M 330M 14.15B 584M 87.14M 77.42M 72.26M 65.86M 124M 8.38B 125M 875M 339M 4.28B 327M 320M 13.74B
Logo Ningbo Menovo Pharmaceutical Co., Ltd.
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and preparations. The Company is mainly engaged in three businesses. The contract development and manufacturing organization (CDMO) business mainly provides pharmaceutical companies with CDMO services for the entire preparation industry chain. The specialty API business is mainly engaged in the production and sales of APIs. The preparation business is mainly engaged in the production and sales of preparations. The Company's main products include valsartan, losartan, perindopril, rosuvastatin calcium, atorvastatin calcium and pregabalin. The Company's products are mainly used in cardiovascular, central nervous, antiviral, hypoglycemic, gastrointestinal and other therapeutic areas. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
2,370
Date Price Change Volume
26-09-30 CN¥28.59 +10.00% 47,551,922
26-09-29 CN¥25.99 -0.54% 37,240,804

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603538 Stock